HuCAL-derived monoclonal antibodies (MorphoSys/Absynth)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHuCAL-derived monoclonal antibodies (MorphoSys/Absynth)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMorphosys Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbsynth Biologics LtdMorphosys Ag
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A